Results 11 to 20 of about 15,617 (227)

Effectiveness of Nigerian Bamboo Activated with Different Activating Agents on the Adsorption of BTX

open access: yesJournal of Applied Sciences and Environmental Management, 2013
The effectiveness of Nigerian Bamboo activated with different activating agents on the adsorption of BTX was investigated. A series of activated carbons was prepared from Nigerian bamboo, carbonized at 400oC – 500oC and impregnated with different ...
FT Ademiluyi, O Braide
doaj   +6 more sources

Hydrothermal Syntheses, Crystal Structures, and Characteristics of a Series of Cd−btx Coordination Polymers (btx = 1,4-Bis(triazol-1-ylmethyl)benzene)

open access: yes, 2016
Four novel cadmium−btx (btx = 1,4-bis(triazol-1-ylmethyl)benzene) coordination polymers [Cd(btx)2(NO3)2]n (1), [Cd(btx)2Cl2]n (2), [Cd(btx)(SO4)(H2O)2]n (3), and [Cd(btx)(S2O7)(H2O)]n (4) have been prepared by hydrothermal reaction (140 or 180 °C) and ...
Huayun Han (2464825)   +6 more
core   +4 more sources

Temporal variations of BTX compounds in Bursa/Turkey atmosphere [PDF]

open access: yes, 2013
Ambient concentrations of C2-C12 volatile organic compounds (VOCs) were measured at Bursa, which is the fourth largest city of Turkey. Two measurement campaigns were carried out between September 14 to November 6, 2005 and March 17 to May 10, 2006. Fifty
CİVAN, MİHRİBAN   +3 more
core   +2 more sources

Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study

open access: yesBMC Musculoskeletal Disorders, 2017
Background Botulinum toxin A (BTX-A) has been used to reduce spasticity in children with cerebral palsy (CP) for decades. The purpose of this study was to analyze to what extent BTX-A treatment was used to treat spasticity in a total population of ...
Maria Franzén   +2 more
doaj   +1 more source

Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2/MyD88 and SNAP23

open access: yesCell & Bioscience, 2020
Background Botulinum toxin type A (BTX-A) was considered to be a new potential drug for neuropathic pain (NP) treatment. Results In vivo, BTX-A attenuated chronic compression injury (CCI)-induced pain in rats, and reduced production of pro-inflammatory ...
Xuan Wang   +7 more
doaj   +1 more source

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis

open access: yesRenal Failure, 2019
The aim of this work was to evaluate the efficacy and safety of botulinum toxin A (BTX-A) treatment in patients with neurogenic detrusor overactivity.
Shang-Jun Wu   +6 more
doaj   +1 more source

Comparison of the effects of modified constraint-induced movement therapy and intensive conventional therapy with a botulinum-a toxin injection on upper limb motor function recovery in patients with stroke

open access: yesLibyan Journal of Medicine, 2019
Stroke is the second leading cause of mortality worldwide and one of the main causes of adult disability. Many studies have suggested that combination therapies provide better outcomes in patients with stroke than monotherapies.
Mohammad Nasb   +4 more
doaj   +1 more source

High-frequency, low-magnitude vibration does not prevent bone loss resulting from muscle disuse in mice following botulinum toxin injection. [PDF]

open access: yesPLoS ONE, 2012
High-frequency, low-magnitude vibration enhances bone formation ostensibly by mimicking normal postural muscle activity. We tested this hypothesis by examining whether daily exposure to low-magnitude vibration (VIB) would maintain bone in a muscle disuse
Sarah L Manske   +3 more
doaj   +1 more source

Search Practices and Search Strategies with BTX

open access: yes, 2010
The practices of BTX users in searching for information with the help of the BTX system. Topics: Both a survey and participant observation were conducted. 1.
Immer, Nikolaus, Zentralarchiv f\ufcr empirische Sozialforschung, Universit\ue4t zu K\uf6ln   +2 more
core   +2 more sources

Botulinum Toxin in the Field of Dermatology: Novel Indications

open access: yesToxins, 2017
Since its approval by the US Food and Drug Administration in 2002 for glabellar wrinkles, botulinum toxin (BTX) has been widely used to correct facial wrinkles. As a result, many consider BTX synonymous with cosmetic dermatology.
Yoon Seob Kim   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy